Intravitreal Bevacizumab for Age-Related Macular Degeneration

• Status: Unknown status
• Trial end date: 2006-09-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to determine whether intravitreal injection of bevacizumab is effective in the treatment of neovascular age related macular degeneration

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Asociación para Evitar la Ceguera en México
• Treatments: Bevacizumab

Criteria

Inclusion Criteria:

• age >50 age related macular degeneration

Exclusion Criteria:

• moderate to severe cataract glaucoma intraocular surgery diabetes mellitus non controlled hypertension coronary artery disease